ASSAY FOR TACROLIMUS
|
phenotype |
|
Laboratory Procedure
|
2
|
3
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Calcineurin Nephrotoxicity
|
disease |
|
Disease or Syndrome
|
3
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2018 |
Arteriolar hyalinosis
|
disease |
|
Acquired Abnormality
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Elevated mean arterial pressure
|
phenotype |
Cardiovascular Diseases
|
Finding
|
10
|
1
|
0.100 |
None |
|
0 |
|
|
|
Therapy-related acute myeloid leukemia and myelodysplastic syndrome
|
disease |
Neoplasms
|
Neoplastic Process
|
11
|
|
0.010 |
None |
< 0.001 |
1 |
|
2002 |
2002 |
Epilepsy in children
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
12
|
1
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Chronic cough
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases
|
Sign or Symptom
|
14
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Elevated systolic blood pressure
|
phenotype |
Cardiovascular Diseases
|
Finding
|
14
|
1
|
0.100 |
None |
|
0 |
|
|
|
Elevated diastolic blood pressure
|
phenotype |
Cardiovascular Diseases
|
Finding
|
14
|
1
|
0.100 |
None |
|
0 |
|
|
|
Clonorchiasis
|
disease |
Infections
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Schizophrenia and related disorders
|
group |
Mental Disorders
|
Disease or Syndrome
|
20
|
5
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2010 |
Encephalopathy, Toxic
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Toxic Encephalitis
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Balkan Nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
34
|
4
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Neurotoxicity Syndromes
|
group |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
34
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Thrombus
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
46
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Hormone measurement
|
group |
|
Laboratory Procedure
|
51
|
134
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Maternal hypertension
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Cardiovascular Diseases
|
Disease or Syndrome
|
52
|
22
|
0.010 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
hypertensive nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
55
|
8
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
stage, prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
58
|
5
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Febrile Neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
58
|
14
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Respiratory Distress Syndrome
|
disease |
|
Disease or Syndrome
|
58
|
9
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Primary Malignant Liver Neoplasm
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
60
|
4
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Genitourinary Cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
60
|
1
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Cancer Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
62
|
4
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2016 |